What is the future trend of Adagraxib price in 2024?

Adagrasib (Adagrasib) was developed for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC), especially those with specific genetic changes (mutations) in KRAS G12C. When traditional treatments fail to effectively curb the progression of the disease, the emergence of adagrasib brings new treatment hope to patients. Mutations in the KRAS gene can cause changes in its protein form, causing cancer cells to grow out of control. Through its active substance adagrasib, adagrasib precisely attaches to the altered proteins in cancer cells and blocks their functions, thereby slowing down cell growth and spread and promoting apoptosis of cancer cells.

The original drug of adagrasib is not currently on the market in the country. This means that if domestic patients want to obtain this drug, they have to turn to overseas purchase channels. However, the price of the original research version of adagrasibu sold overseas is high. A box of 200mg*180 tablets costs up to hundreds of thousands of yuan, and this price is also affected by factors such as exchange rates and fluctuates. This undoubtedly brings a heavy financial burden to many patients.

Will the price of adagrasib decrease in the future? This is a matter of great concern. Judging from market rules, as time goes by, when more pharmaceutical companies develop and sell adagrasib, its price is expected to gradually decrease. This is because the intensification of market competition will prompt pharmaceutical companies to adopt pricing strategies to compete for market share.

In addition, generic drugs of adagrasib have appeared in overseas markets. The ingredients of this generic drug are highly consistent with the original drug, but the price is more affordable. For example, the generic drug produced by Lucius Pharmaceutical Factory in Laos has a specification of 200mg*90 tablets per box and sells for only more than 4,000 yuan. Although the price is still affected by factors such as exchange rates, compared with the original drug, this price has greatly reduced the financial pressure on patients.